<!doctype html>
<html>
<head>
<title>Cheyenne</title>
<!--[if IE]>
<meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1"/>
<![endif]-->
<meta charset="utf-8"/>
<meta name="application-name" content="FileMan Schema"/>
<meta name="fragment" content="!">
<link rel='stylesheet' href='fmBase.css' type='text/css'>
</head>
<body>
<div id="header">
<h1 id="logo"><a href="index.html">Cheyenne Schema Browser</a></h1>
</div>
<div id="fmql">
<div class="fmqlResults"><div id="resultsHeader"><h1><a href='index.html'>Files</a> > SITE-GROUP FOR ONCOLOGY</h1></div><div id="results"><dl><dt>name</dt><dd>SITE-GROUP FOR ONCOLOGY</dd><dt>number</dt><dd>164.2</dd><dt>location</dt><dd>^ONCO(164.2,</dd><dt>description</dt><dd>Contains major site-groups for the Oncology package. It contains ALL theACOS Site-Specific Surgery Codes. In addition, it also contains the SEERExtension and Lymph node coding - sharing that function with file 164. The "F" cross-reference of the TOPOGRAPHY Field (#.01) of the TOPOGRAPHY Multiple (#10) sets an index under ^ONCO(164.2,"F").  An index under^ONCO(164.2,"G") is set by both the "G" cross-reference of theICDO-1 TOPOGRAPHY Field (#.02) of the TOPOGRAPHY Multiple (#10),and by the "AC" cross-reference of the TOPOGRAPHY Field (#.01)of the TOPOGRAPHY Multiple (#10) of the ICDO-1 SITE FOR ONCOLOGYFile (#169.2).</dd><dt>applicationGroups</dt><dd>ONCO</dd><dt>Fields</dt><dd><table><thead><tr><th>#</th><th>Name</th><th>Location</th><th>Type</th><th>Details</th><th>Index</th><th>Description</th></tr></thead><tbody><tr><td>.01</td><td>name(+)</td><td>0;1</td><td>FREE TEXT</td><td></td><td>B</td><td>FREE TEXT FIELD FOR RECORDING NAME.</td></tr><tr><td>.02</td><td>ajcc staging</td><td>0;2</td><td>SET OF CODES</td><td>1:YES<br/>Y:YES<br/></td><td></td><td>RECORDS THE AJCC STAGE.</td></tr><tr><td>1</td><td>key word</td><td>1;0</td><td>MULTIPLE</td><td><a href="164_21.html">164.21</a></td><td></td><td>This field is a free-text KWIC cross-reference.</td></tr><tr><td>10</td><td>topography</td><td>T;0</td><td>MULTIPLE</td><td><a href="164_22.html">164.22</a></td><td></td><td>POINTS TO THE FILE CONTAINING TOPOGRAPHY CODES.</td></tr><tr><td>20</td><td>morphology</td><td>M;0</td><td>MULTIPLE</td><td><a href="164_23.html">164.23</a></td><td></td><td>Morphologies associated with this SITE-GP.</td></tr><tr><td>43</td><td>extension code set-1st ed</td><td>E;1</td><td>POINTER</td><td><a href="164_5.html">164.5</a></td><td></td><td>This field identifies the set of codes used to characterize extensionfor this site group in the first edition of SEER Extent ofDisease Codes and Coding Instructions.</td></tr><tr><td>43.01</td><td>extension code set-2nd ed</td><td>E;2</td><td>POINTER</td><td><a href="164_5.html">164.5</a></td><td></td><td>This field identifies the set of codes used to characterize extensionfor this site group in the second edition of SEER Extent ofDisease Codes and Coding Instructions.</td></tr><tr><td>43.02</td><td>extension code set-3rd ed</td><td>E;3</td><td>POINTER</td><td><a href="164_5.html">164.5</a></td><td></td><td>This field identifies the set of codes used to characterize extensionfor this site group in the third edition of SEER Extent ofDisease Codes and Coding Instructions.</td></tr><tr><td>53</td><td>lymph node code set-1st ed</td><td>L;1</td><td>POINTER</td><td><a href="164_5.html">164.5</a></td><td></td><td>This field identifies the set of codes used to characterize lymph node involvement for this site group in the first edition of SEER Extent of Disease Codes and Coding Instructions.</td></tr><tr><td>53.01</td><td>lymph node code set-2nd ed</td><td>L;2</td><td>POINTER</td><td><a href="164_5.html">164.5</a></td><td></td><td>This field identifies the set of codes used to characterize lymph nodeinvolvement for this site group in the second edition of SEER Extent ofDisease Codes and Coding Instructions.</td></tr><tr><td>53.02</td><td>lymph node code set-3rd ed</td><td>L;3</td><td>POINTER</td><td><a href="164_5.html">164.5</a></td><td></td><td>This field identifies the set of codes used to characterize lymph nodeinvolvement for this site group in the third edition of SEER Extent ofDisease Codes and Coding Instructions.</td></tr><tr><td>70</td><td>grade</td><td>G;0</td><td>MULTIPLE</td><td><a href="164_25.html">164.25</a></td><td></td><td>FREE TEXT FIELD FOR RECORDING ADDITIONAL GRADE INFORMATION.</td></tr><tr><td>71</td><td>histologic</td><td>0;3</td><td>BOOLEAN</td><td>1:Yes<br/>0:No<br/></td><td></td><td>This field is referenced by the Screen for the SITE/GP Field (#.01) in theONCOLOGY PRIMARY File (#165.5).  Histologic site groups (lymphomas,melanoma, leukemia, mycosis fungoides) should not be chosen as primarysite groups.</td></tr></tbody></table></dd></dl></div></div><hr><div class="fmqlResults"><h2>Referenced by 3 types</h2><ol><li><a href="160.html">ONCOLOGY PATIENT</a> (160) -- </li><li><a href="164.html">ICDO TOPOGRAPHY</a> (164) -- surgery coding, default primary site group</li><li><a href="165_5.html">ONCOLOGY PRIMARY</a> (165.5) -- site/gp, cancer #1, cancer #2, cancer #3, cancer #4</li></ol></div>
</div>
<div id="footer"><a href="http://www.caregraf.info">Master FileMan's Data</a>&trade; (c) 2017 <span id="flogo"><a href="http://www.caregraf.info">Caregraf</a></span></div>
</body>
</html>
